Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:128-135, 2006
DOI: 10.2337/diabetes.55.01.06.db05-0954
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Florez, J. C.
Right arrow Articles by Groop, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Florez, J. C.
Right arrow Articles by Groop, L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Brief Genetics Reports

High-Density Haplotype Structure and Association Testing of the Insulin-Degrading Enzyme (IDE) Gene With Type 2 Diabetes in 4,206 People

Jose C. Florez1,2,3,4, Steven Wiltshire5, Christina M. Agapakis1,3, Noël P. Burtt3, Paul I.W. de Bakker1,3,6, Peter Almgren7, Kristina Bengtsson Boström8, Tiinamaija Tuomi9, Daniel Gaudet10, Mark J. Daly2,3, Joel N. Hirschhorn3,6,11, Mark I. McCarthy5,12, David Altshuler1,2,3,4,6, and Leif Groop7

1 Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts
2 Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
3 Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts
4 Department of Medicine, Harvard Medical School, Boston, Massachusetts
5 Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K
6 Department of Genetics, Harvard Medical School, Boston, Massachusetts
7 Department of Endocrinology, University Hospital MAS, Lund University, Malmö, Sweden
8 Department of Clinical Science, University Hospital MAS, Lund University, Malmö, Sweden
9 Department of Medicine, Helsinki University Central Hospital; Folkhalsan Genetic Institute, Folkhalsan Research Center, and Research Program for Molecular Medicine, University of Helsinki, Helsinki, Finland
10 Chicoutimi Hospital, University of Montreal Community Genomic Center, Quebec, Canada
11 Divisions of Genetics and Endocrinology, Children’s Hospital, Boston, Massachusetts
12 Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, U.K

Address correspondence and reprint requests to Jose C. Florez, Diabetes Unit, Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114. E-mail: jcflorez{at}partners.org

Abbreviations: AUC, area under the curve; CEPH, Centre d’Etude du Polymorphisme Humain; HOMA-IR, homeostasis model assessment of insulin resistance; IDE, insulin-degrading enzyme; SNP, single nucleotide polymorphism

The insulin-degrading enzyme is responsible for the intracellular proteolysis of insulin. Its gene IDE is located on chromosome 10, in an area with suggestive linkage to type 2 diabetes and related phenotypes. Due to the impact of genetic variants of this gene in rodents and the function of its protein product, it has been proposed as a candidate gene for type 2 diabetes. Various groups have explored the role of the common genetic variation of IDE on insulin resistance and reported associations of various single nucleotide polymorphisms (SNPs) and haplotypes on both type 2 diabetes and glycemic traits. We sought to characterize the haplotype structure of IDE in detail and replicate the association of common variants with type 2 diabetes, fasting insulin, fasting glucose, and insulin resistance. We assessed linkage disequilibrium, selected single-marker and multimarker tags, and genotyped these markers in several case-control and family-based samples totalling 4,206 Caucasian individuals. We observed no statistically significant evidence of association between single-marker or multimarker tests in IDE and type 2 diabetes. Nominally significant differences in quantitative traits are consistent with statistical noise. We conclude that common genetic variation at IDE is unlikely to confer clinically significant risk of type 2 diabetes in Caucasians.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
N. Grarup, C. S. Rose, E. A. Andersson, G. Andersen, A. L. Nielsen, A. Albrechtsen, J. O. Clausen, S. S. Rasmussen, T. Jorgensen, A. Sandbaek, et al.
Studies of Association of Variants Near the HHEX, CDKN2A/B, and IGF2BP2 Genes With Type 2 Diabetes and Impaired Insulin Release in 10,705 Danish Subjects: Validation and Extension of Genome-Wide Association Studies
Diabetes, December 1, 2007; 56(12): 3105 - 3111.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Im, M. Manolopoulou, E. Malito, Y. Shen, J. Zhao, M. Neant-Fery, C.-Y. Sun, S. C. Meredith, S. S. Sisodia, M. A. Leissring, et al.
Structure of Substrate-free Human Insulin-degrading Enzyme (IDE) and Biophysical Analysis of ATP-induced Conformational Switch of IDE
J. Biol. Chem., August 31, 2007; 282(35): 25453 - 25463.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
S. J. Macdonald and A. D. Long
Joint Estimates of Quantitative Trait Locus Effect and Frequency Using Synthetic Recombinant Populations of Drosophila melanogaster
Genetics, June 1, 2007; 176(2): 1261 - 1281.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. M. Clee and A. D. Attie
The Genetic Landscape of Type 2 Diabetes in Mice
Endocr. Rev., February 1, 2007; 28(1): 48 - 83.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Saxena, L. Gianniny, N. P. Burtt, V. Lyssenko, C. Giuducci, M. Sjogren, J. C. Florez, P. Almgren, B. Isomaa, M. Orho-Melander, et al.
Common Single Nucleotide Polymorphisms in TCF7L2 Are Reproducibly Associated With Type 2 Diabetes and Reduce the Insulin Response to Glucose in Nondiabetic Individuals.
Diabetes, October 1, 2006; 55(10): 2890 - 2895.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.